Angiodynamics, Inc.: Clinical Trials

6 trials sponsored by Angiodynamics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 unknown. 6 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Recruiting 2, Unknown 1
Phase 12Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow Angiodynamics, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
Irreversible electroporation, Stereotactic body radiotherapy - Colorectal Cancer, Liver Metastases
Phase 2 / Phase 3RecruitingAmsterdam UMC, location VUmc782024-08-202024-08-23
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
IP-001 - Colorectal Cancer, Liver Metastases
Phase 1 / Phase 2RecruitingM.R. Meijerink1202024-07-102025-07-03
Safety and Feasibility of IRE for SRMs
Irreversible Electroporation - Kidney Cancer
Phase 2UnknownDr. Prof. M.P. Laguna Pes202016-07-012016-09-27
NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer
NanoKnife Low Energy Direct Current (LEDC) System Ablation - Pancreatic Adenocarcinoma
Phase 2CompletedAngiodynamics, Inc.102011-05-012016-11-08
Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation
AngioDynamics (previously RITA Med,Inc) radiofrequency delivery system (consisting of a generator and Starburst XL probe) - Cancer of the Breast
Phase 1 / Phase 2CompletedUniversity of Arkansas1072004-09-012015-11-24
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation
RF ablation (Rita Medical Systems Model 1500x) - Non Small Cell Lung Cancer, Pulmonary Metastases
Phase 2CompletedAngiodynamics, Inc.1062001-07-012008-06-05

Conditions studied

Colorectal Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Kidney Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Interventions

Electroporation (2)  ·  Drug Delivery Systems (1)  ·  N-dihydrogalactochitosan (1)  ·  Radiosurgery (1)

Countries

Netherlands (3)  ·  Italy (2)  ·  United States (2)  ·  Australia (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Martijn R. Meijerink, Prof. (2)  ·  Claudio Bassi, M.D. (1)  ·  Maria Pilar Laguna Pes, MD, PhD (1)  ·  Riccardo Lencioni, MD (1)  ·  V. Suzanne Klimberg, M.D. (1)

Results publications

PMID 18565793, PMID 28209559

NIH funding

2023 (1)